Results 41 to 50 of about 137,343 (204)

Vogt-Koyanagi-Harada disease: a clinical case report [PDF]

open access: yes, 2023
Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu”, Chişinău, Republica MoldovaIntroducere. Boala Vogt-Koyanagi-Harada (VKH) (sindromul uveomeningeal) se caracterizează prin uveita bilaterală și dereglări somatice generale precum ...
Magla, Tatiana   +3 more
core   +1 more source

Mucosal‐Associated Invariant T Cells in Health and Disease

open access: yesMedComm, Volume 7, Issue 10, October 2026.
The roles of MAIT cells in health and disease and their therapeutic applications. In healthy individuals, riboflavin metabolites secreted by commensal bacteria at mucosal sites are presented by MR1, leading to the activation of MAIT cells. Activated MAIT cells can maintain the barrier integrity of mucosal tissues in a steady state or migrate to the ...
Yu Zhao   +5 more
wiley   +1 more source

An Integrated Proteomics and Genomics Approach to Identify Essential Protein Kinases During Human Trophoblast Development

open access: yesThe FASEB Journal, Volume 40, Issue 17, 15 September 2026.
Integrated quantitative proteomic, phosphoproteomic, and transcriptomic analyses of human trophoblast stem cells identify stage‐specific kinase signaling networks that regulate trophoblast self‐renewal and differentiation into syncytiotrophoblasts and extravillous trophoblasts.
Rajnish Kumar   +3 more
wiley   +1 more source

A COVID-19 perspective of Vogt–Koyanagi–Harada disease

open access: yesIndian Journal of Ophthalmology, 2023
Vogt–Koyanagi–Harada (VKH) disease, a bilateral granulomatous panuveitis associated with multisystem involvement, is a T-cell-mediated autoimmune disorder in which cytotoxic T-cell target melanocytes in genetically susceptible individuals.
Parthopratim Dutta Majumder   +3 more
doaj   +1 more source

Exudative Retinal Detachments: A Rare Adverse Effect of Topiramate

open access: yesClinical Case Reports, Volume 14, Issue 6, June 2026.
ABSTRACT Topiramate‐induced multifocal exudative retinal detachment is a rare but potentially vision‐threatening adverse effect. We report a 59‐year‐old woman with idiopathic intracranial hypertension who developed painless bilateral blurry vision and color desaturation 8 days after initiation of topiramate 25 mg twice daily.
Sarah Aljefri   +3 more
wiley   +1 more source

Relato de Caso: Síndrome de Vogt-Koyanagi-Harada / Case Report: Vogt-Koyanagi-Harada Syndrome [PDF]

open access: yes, 2021
Vogt–Koyanagi–Harada (VKH) disease is an inflammatory and autoimmune condition characterized by panuveitis, serous retinal detachments, and extraocular manifestations of the auditory, integumentary, and central nervous systems (CNS).
Caiado, Gustavo Coelho   +3 more
core   +1 more source

Solo diagnosticamos lo que conocemos: síndrome de Vogt Koyanagi-Harada (VKH)

open access: yesRepertorio de Medicina y Cirugía
Objetivo: se presenta un caso de síndrome de Vogt-Koyanagi-Harada en una paciente joven sin antecedentes de importancia. Presentación del caso: paciente femenina de 23 años que consultó por cuadro clínico de 1 mes de evolución caracterizado por pérdida ...
Pablo Salomón Montes Arcón   +4 more
doaj   +1 more source

A Systematic Review of Literature: TNF‐α Blockers and JAK Inhibitors for the Treatment of Stevens‐Johnson Syndrome, Toxic Epidermal Necrolysis, and Severe Forms of Erythema Multiforme

open access: yesHealth Science Reports, Volume 9, Issue 6, June 2026.
ABSTRACT Background and Aims Stevens‐Johnson Syndrome (SJS), toxic epidermal necrolysis (TEN), and erythema multiforme major (EM major) are severe dermatologic conditions characterized by varying degrees of skin detachment and involvement of mucosal membranes, often triggered by drug reactions or infections.
Sadaf Salehi   +6 more
wiley   +1 more source

Rate of Hearing Loss in Platinum‐Naïve Patients Receiving Immune Checkpoint Inhibitors

open access: yesOtolaryngology–Head and Neck Surgery, Volume 174, Issue 5, Page 1289-1297, May 2026.
Abstract Objective Hearing loss from immune checkpoint inhibitors (ICIs) has been documented in case reports and case series. We present the largest retrospective study investigating the rate of ICI‐related ototoxicity in a monitored cohort of platinum‐naïve patients. Study Design Retrospective cohort study. Setting Tertiary‐care center.
Kaitlyn A. Brooks   +11 more
wiley   +1 more source

Vogt-Koyanagi-Harada syndrome: A case report [Vogt-Koyanagi-Harada sendromu: Bir olgu sunumu]

open access: yes, 2008
Vogt-Koyanagi-Harada syndrome is a rare, inflammatory disease with manifestations affecting the ocular, central nervous, auditory-vestibular systems. It affects pigmented individuals between 20-50 years old.
Koç F., Bozdemir H.
core   +1 more source

Home - About - Disclaimer - Privacy